康臣葯業：2022中期報告.pdf

1、Kidney MedicinesHepatobiliary MedicinesOrthopedics MedicinesDermatologic MedicinesContrast MediumGastroenterology MedicinesGynaecology and Paediatric Medicines腎科藥物肝膽藥物骨科藥物皮膚科藥物對比劑消化系統藥物婦兒藥物中期報告Interim Report2022 Corporate Information公司資料2-4Financial Highlights財務摘要5Management Discussion and Analysis管

2、理層討論及分析6-16Consolidated Statement of Profit or Loss綜合損益表17Consolidated Statement of Profit or Loss and Other Comprehensive Income綜合損益及其他全面收益表18Consolidated Statement of Financial Position綜合財務狀況表19-20Consolidated Statement of Changes in Equity綜合權益變動表21-23Condensed Consolidated Cash Flow Statement簡明綜合

3、現金流量表24Notes to the Unaudited Interim Financial Report未經審核中期財務報告附註25-52Review Report審閱報告53-54Other Information其他資料55-72Contents 目錄CONSUN PHARMACEUTICAL GROUP LIMITED 康臣葯業集團有限公司2公司資料Corporate InformationDIRECTORSExecutive DirectorsMr.An Meng(Chairman)Ms.Li Qian(Founder,Vice Chairlady,Chief Executive

4、Officer)Professor Zhu QuanMr.Xu HanxingNon-Executive DirectorMs.Zhang LihuaIndependent Non-Executive DirectorsMr.Su YuanfuMr.Feng ZhongshiMs.Chen YujunAUDIT COMMITTEEMs.Chen Yujun(Chairlady)Mr.Feng ZhongshiMr.Su YuanfuNOMINATION COMMITTEEMr.Su Yuanfu(Chairman)Mr.An MengMs.Chen YujunREMUNERATION COMM

5、ITTEEMr.Feng Zhongshi(Chairman)Ms.Li QianMr.Su YuanfuCOMPANY SECRETARYMr.Yau Chi Ming(CPA)董事執行董事安猛先生（主席）黎倩女士（創始人、副主席、首席執行官）朱荃教授徐瀚星先生非執行董事張麗華女士獨立非執行董事蘇元福先生馮仲實先生陳玉君女士審核委員會陳玉君女士（主席）馮仲實先生蘇元福先生提名委員會蘇元福先生（主席）安猛先生陳玉君女士薪酬委員會馮仲實先生（主席）黎倩女士蘇元福先生公司秘書丘志明先生（執業會計師）INTERIM REPORT 2022 中期報告3公司資料Corporate Information

6、AUTHORISED REPRESENTATIVES FOR THE PURPOSE OF THE LISTING RULESMr.An MengMr.Yau Chi MingAUDITORKPMGPublic Interest Entity Auditor registered in accordancewith the Financial Reporting Council Ordinance8th Floor,Princes Building10 Chater Road,Central,Hong KongLEGAL ADVISER(AS TO HONG KONG LAW)Li&Partn